ASCO 2014: Dr. Kipps Discusses Targeted Therap... - CLL Support

CLL Support

22,367 members38,474 posts

ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab in the Treatment of CLL (chronic lymphocytic leukemia) in my latest blog post at bkoffman.blogspot.com where I reference the latest research and the data from ASH last December.

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...

You may also like...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

first part of my interview with Dr. Kipps at ASH 2018, he discusses resistance and how to possibly...

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

another interview from ASH 2013 that I just posted on my blog http://bkoffman.blogspot.com , Dr....

Targeted therapy drugs

End of suspense! Here is Dr. Koffman's ASCO 2020 \"Top Pick\" #1!

patients with chronic lymphocytic leukemia (CLL). https://cllsociety.org/2020/08/asco-2020-top-12-1-

Has anyone been on the combination therapy of Venetoclax, Ibrutinib and Obinutuzumab?

could hear from someone who has had the combination of Venetoclax, Ibrutinib and Obinutuzumab...